Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 217 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BONHOMME B, Godbert Y, Perot G, Alghuzlan A, et al
    Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0254.
    PubMed     Text format     Abstract available


  2. TAVARELLI M, Sarfati J, Chereau N, Tissier F, et al
    Heterogeneous prognoses for pT3 papillary thyroid carcinomas and impact of delayed risk stratification.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0512.
    PubMed     Text format     Abstract available


  3. LEE SE, Hwang TS, Choi YL, Kim WY, et al
    Molecular profiling of papillary thyroid carcinoma in Korea with high prevalence of BRAF V600E mutation.
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0547.
    PubMed     Text format     Abstract available


  4. CIPRIANI NA, Agarwal S, Dias-Santagata D, Faquin WC, et al
    Clear cell change in thyroid carcinoma: a clinicopathologic and molecular study with identification of variable genetic anomalies.
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0631.
    PubMed     Text format     Abstract available


    January 2017
  5. PAEPEGAEY AC, Cochand-Priollet B, Louiset E, Sarfati PO, et al
    Long-term control of hypercortisolism by vandetanib in a medullary thyroid carcinoma with a somatic RET mutation.
    Thyroid. 2017 Jan 9. doi: 10.1089/thy.2016.0334.
    PubMed     Text format     Abstract available


  6. RAO SN, Zafereo M, Dadu R, Busaidy N, et al
    Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jan 9. doi: 10.1089/thy.2016.0395.
    PubMed     Text format     Abstract available


  7. VAN DER WARDT RA, Persoon AC, Klein Hesselink EN, Links TP, et al
    Long-term follow-up for differentiated thyroid carcinoma patients - a reconsideration.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0314.
    PubMed     Text format     Abstract available


  8. XU B, Tuttle RM Md, Sabra M, Ganly I, et al
    Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinico-Pathologic and Molecular Characteristics.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0582.
    PubMed     Text format     Abstract available


    November 2016
  9. CORDIOLI MI, Moraes L, Bastos AU, Besson P, et al
    Fusion oncogenes are the main genetic events found in sporadic papillary thyroid carcinomas from children.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  10. LUBITZ CC, De Gregorio L, Fingeret AL, Economopoulos KP, et al
    Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  11. NIKITSKI A, Rogounovitch T, Bychkov A, Takahashi M, et al
    Genotype analyses in the Japanese and Belarusian populations reveal independent effects of rs965513 and rs1867277 but do not support the role of FOXE1 polyalanine tract length in conferring risk for papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    October 2016
  12. WEINBERGER P, Ponny SR, Xu H, Bai S, et al
    Cell Cycle M-phase Genes are Highly Upregulated in Anaplastic Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  13. SANDULACHE VC, Williams MD, Lai SY, Lu C, et al
    Real-time genomic characterization utilizing circulating cell-free DNA in patients with anaplastic thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  14. KIM SK, Park I, Hur N, Lee JH, et al
    Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  15. CORREA NL, de Sa LV, Corbo R
    Estimation of second primary cancer risk after treatment with radioactive iodine for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  16. LANG BH, Shek T, Chan AO, Lo CY, et al
    Significance of size of persistent/recurrent central nodal disease on surgical morbidity and response to therapy in reoperative neck dissection for papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  17. KIM SK, Park I, Woo JW, Lee JH, et al
    Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size < 4 cm.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  18. KIM M, Kim WG, Park S, Kwon H, et al
    The Initial Size of Metastatic Lesions is the Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  19. HONG S, Yu S, Li J, Yin Y, et al
    MiR-20b Displays Tumor Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    September 2016
  20. XU JY, Grubbs EG, Waguespack SG, Jimenez C, et al
    Medullary Thyroid Carcinoma Associated with Germline RET K666N Mutation.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  21. TOMODA C, Sugino K, Matsuzu K, Uruno T, et al
    Cervical lymph node metastases after thyroidectomy for papillary thyroid carcinoma usually remain stable for years.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  22. GRUBBS EG, Williams MD, Scheet P, Vattathil S, et al
    The role of CDKN2C copy number in sporadic medullary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  23. PANKRATZ DG, Hu Z, Kim SY, Monroe RJ, et al
    Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  24. ESSIG G JR, Porter K, Schneider DF, Arpaia D, et al
    MULTIFOCALITY IN SPORADIC MEDULLARY THYROID CARCINOMA: AN INTERNATIONAL MULTICENTER STUDY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    August 2016
  25. DA FONSECA FL, Yamanaka PK, Kato JM, Matayoshi S, et al
    LACRIMAL SYSTEM OBSTRUCTION AFTER RADIOIODINE THERAPY IN DIFFERENTIATED THYROID CARCINOMAS: A PROSPECTIVE COMPARATIVE STUDY.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  26. SCHEFFEL RS, Zanella AB, Dora JM, Maia AL, et al
    Timing of radioactive iodine administration does not influence outcomes in patients with differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  27. PRAGER G, Koperek O, Mayerhofer M, Muellauer L, et al
    Sustained Response to Vemurafenib in an BRAF V600E-mutated Anaplastic Thyroid Carcinoma Patient.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  28. LIKHTEROV I, Osorio M, Moubayed SP, Hernandez-Prera J, et al
    The Ethical Implications of the Reclassification of Non Invasive-Follicular Variant Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  29. XU B, Ibrahimpasic T, Wang LY, Sabra M, et al
    Clinico-Pathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    July 2016
  30. KIM SH, Roh JL, Gong G, Cho KJ, et al
    Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-up.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  31. LEE DY, Won JK, Choi HS, Park DJ, et al
    Recurrence and survival after gross total removal of resectable undifferentiated or poorly differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  32. OPSAHL EM, Schlichting E, Helset K, Svartberg J, et al
    A Nationwide study of multiple endocrine neoplasia type 2A in Norway. Predictive avd prognostic factors for the clinical course of medullary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  33. ATALLAH V, Hocquelet A, Do Cao C, Zerdoud S, et al
    Activity and safety of Sunitinib in patients with advanced radio-iodine refractory thyroid carcinoma: a retrospective analysis of 57 patients.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    June 2016
  34. JENDRZEJEWSKI JP, Liyanarachchi S, Nagy R, Senter L, et al
    Papillary thyroid carcinoma: Association between germline DNA variant markers and clinical parameters.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  35. KIM SK, Park I, Woo JW, Lee JH, et al
    Follicular and Diffuse Sclerosing Variant Papillary Thyroid Carcinomas as Independent Predictive Factors of Loco-regional Recurrence: A Comparison Study Using Propensity Score Matching.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  36. VALDERRABANO P, Klippenstein DL, Tourtelot JB, Ma Z, et al
    The new ATA sonographic patterns for thyroid nodules perform well in medullary thyroid carcinoma: Institutional experience, systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    May 2016
  37. WONG KS, Angell TE, Strickland KC, Alexander EK, et al
    Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  38. DANIELS GH
    Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture.
    Thyroid. 2016.
    PubMed     Text format    


  39. LEE SE, Hwang TS, Choi YL, Han HS, et al
    Prognostic significance of TERT promoter mutations in papillary thyroid carcinomas in a BRAF V600E mutation-prevalent population.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    April 2016
  40. DU E, Wenig B, Su HK, Rowe ME, et al
    Inter-observer Variation in the Pathologic Identification of Extranodal Extension in Nodal Metastasis from Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    March 2016
  41. LATROFA F, Ricci D, Sisti E, Piaggi P, et al
    Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  42. JEON M, Chun SM, Kim D, Kwon H, et al
    Genomic alterations of anaplastic thyroid carcinoma detected by targeted massive parallel sequencing in a BRAFV600E mutation-prevalent area.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  43. KIM SK, Woo JW, Park I, Lee JH, et al
    Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  44. LEE YH, Seo HS, Suh SI, Ryoo I, et al
    A Feasibility Study of a Contrast-Enhanced Multi-detector CT (64 channels) Protocol for Papillary Thyroid Carcinoma: The Influence of Different Scan Delays on Tumor Conspicuity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  45. SU HK, Wenig B, Haser GC, Rowe ME, et al
    Inter-observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  46. ARAGON HAN P, Kim HS, Cho S, Fazeli R, et al
    Association of BRAF Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    February 2016
  47. LIN JD, Fu SS, Chen JY, Lee CH, et al
    Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAFV600E Mutation and BRAF Pseudogene.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  48. NIXON IJ, Wang LY, Migliacci JC, Eskander A, et al
    An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  49. URKEN ML, Haser GC, Likhterov I, Wenig B, et al
    The impact of metastatic lymph nodes on risk stratification in differentiated thyroid cancer: Have we reached a higher level of understanding?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  50. KOWALSKA A, Walczyk A, Kowalik A, Palyga I, et al
    Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF Mutation: A Single-Institution Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  51. SABRA MM, Ghossein R, Tuttle RM
    Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  52. GANDHI A, Wong KK, Gross M, Avram A, et al
    Lingual Thyroid Ectopia: Diagnostic SPECT/CT imaging and Radioactive Iodine Treatment.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  53. BERBER E, Bernet V, Fahey T 3rd, Kebebew E, et al
    American Thyroid Association Statement on Remote Access Thyroid Surgery.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  54. GULEC SA, Kuker RA, Goryawala M, Fernandez C, et al
    I-124 PET/CT IN PATIENTS WITH DIFFERENTIATED THYROID CANCER: CLINICAL AND QUANTITATIVE IMAGE ANALYSIS.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  55. BAKKAR S, Frustaci G, Papini P, Fregoli L, et al
    Track Recurrence After Robotic Transaxillary Thyroidectomy; A Case Report Highlighting The Importance of Controlled Surgical Indications and Addressing Unprecedented Complications.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  56. GRECO A, Albanese S, Auletta L, Mirabelli P, et al
    High-frequency ultrasound-guided injection for the generation of a novel orthotopic mouse model of human thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  57. ROSARIO PW, Carvalho M, Mourao GF, Calsolari MR, et al
    Comparison of antithyroglobulin antibodies concentrations before and after ablation with 131I as predictor of structural disease in differentiated thyroid carcinoma patients with undetectable basal thyroglobulin and negative neck ultrasonography.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  58. BALACHANDAR S, La Quaglia M, Tuttle RM, Heller G, et al
    Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
    Thyroid. 2016;26:219-26.
    PubMed     Text format     Abstract available


    January 2016
  59. HEATON CM, Chang JL, Orloff LA
    Prognostic implications of lymph node yield in central and lateral neck dissections for well-differentiated papillary thyroid carcinoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  60. SUH CH, Baek JH, Choi YJ, Lee JH, et al
    Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: A systematic review and meta-analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  61. KITAHARA CM, McCullough M, Franceschi S, Rinaldi S, et al
    Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  62. ANGELL TE, Lechner MG, Smith AM, Martin SE, et al
    Circulating Myeloid Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  63. NA DG, Baek JH, Sung JY, Kim JH, et al
    Thyroid Imaging Reporting and Data System for Risk Stratification of Thyroid Nodules: Categorization Based on Solidity and Echogenicity.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  64. AHN HY, Chung YJ, Park KY, Cho BY, et al
    Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  65. BRITO JP, Ito Y, Miyauchi A, Tuttle RM, et al
    A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
    Thyroid. 2016;26:144-9.
    PubMed     Text format     Abstract available


    December 2015
  66. LEE L, Mitmaker EJ, Chabot JA, Lee JA, et al
    Cost-Effectiveness of Diagnostic Lobectomy Versus Observation for Thyroid Nodules Greater than 4 cm.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  67. ALZAHRANI AS, Qasem E, Murugan AK, Al-Hindi HN, et al
    Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  68. CASTRONEVES LA, Negrao MV, Freitas RM, Papadia C, et al
    Sorafenib for the treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  69. SAWKA AM, Brierley J, Tsang RW, Rotstein L, et al
    Unmet Information Needs of Low Risk Thyroid Cancer Survivors.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  70. CHEN Y, Sadow PM, Suh H, Lee KE, et al
    BRAFV600E is correlated with recurrence of papillary thyroid microcarcinoma: A systematic review, multi-institutional primary data analysis, and meta-analysis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  71. ITO Y, Miyauchi A, Kudo T, Ota H, et al
    Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  72. SUH CH, Baek JH, Lee JH, Choi YJ, et al
    The role of core-needle biopsy as a first-line diagnostic tool for initially detected thyroid nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  73. BIKAS A, Van Nostrand D, Jensen KE, Desale S, et al
    Metformin Attenuates <sup>131</sup>I - Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  74. NIKITA ME, Jiang W, Cheng SM, Hantash FM, et al
    Mutational analysis in Pediatric Thyroid Cancer and correlations with age, ethnicity and clinical presentation.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    November 2015
  75. PITOIA F, Miyauchi A
    2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer and their Implementation in Various Care Settings.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  76. KIM JW, Roh JL, Gong G, Cho KJ, et al
    Treatment Outcomes and Risk Factors for Recurrence after Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  77. ESPIARD S, Petyt G, Lion G, Beron A, et al
    Ectopic Subcutaneous Implantation of Thyroid Tissue after Gasless Transaxillary Robotic Thyroidectomy for Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  78. JEON M, Kim WG, Choi YM, Kwon H, et al
    Features predictive of distant metastasis in papillary thyroid microcarcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  79. LIU X, Medici M, Kwong N, Angell TE, et al
    Bethesda Categorization of Thyroid Nodule Cytology & Prediction of Thyroid Cancer Type and Prognosis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  80. BERNARDI S, Lanzilotti V, Papa G, Panizzo N, et al
    Full-thickness skin burn caused by radiofrequency ablation of a benign thyroid nodule.
    Thyroid. 2015.
    PubMed     Text format    


  81. DE NAPOLI L, Bakkar S, Ambrosini CE, Materazzi G, et al
    Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  82. LEE DY, Won JK, Lee SH, Park DJ, et al
    Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    October 2015
  83. HAUGEN BR MD, Alexander EK, Bible KC, Doherty G, et al
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  84. COURA-FILHO GB, Carvalho JW, Buchpiguel CA, Sapienza MT, et al
    Effects of thyroid hormone withdrawal and recombinant human TSH on glomerular filtration rate during radioiodine therapy for well-differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  85. AN JH, Yul H, Ahn HY, Keam B, et al
    A Possible Association Between Thyroid Cancer and Breast Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  86. CIPRIANI NA, Nagar S, Kaplan SP, White MG, et al
    Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What are the Prognostic Implications?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  87. CHOI YJ, Baek JH, Baek S, Shim WH, et al
    Web-based Malignancy Risk Estimation for Thyroid Nodules using Ultrasonography Characteristics: Development and Validation of a Predictive Model.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  88. KHOKHAR MT, Day KM, Sangal RB, Ahmedli NM, et al
    Preoperative High-Resolution Ultrasound for the Assessment of Malignant Central Compartment Lymph Nodes In Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  89. ASCHEBROOK-KILFOY B, James BC, Nagar S, Kaplan S, et al
    Risk Factors for Decreased Quality of Life in Thyroid Cancer Survivors: Initial Findings from the North American Thyroid Cancer Survivorship Study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  90. PATEL DT, Kitahara CM, Park Y, Liao LM, et al
    Thyroid Cancer and Nonsteroidal Antiinflammatory Drug Use: A Pooled Analysis of Patients Over 40 years of Age.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  91. ODA H, Miyauchi A, Ito Y, Yoshioka K, et al
    Incidences of Unfavorable Events in the Management of Low-risk Papillary Microcarcinoma of the Thyroid by Active Surveillance vs. Immediate Surgery.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    September 2015
  92. FAN N, Talaga M, Brown R, Fueri A, et al
    Glycan-dependent mutual and reversible sequestration of two thyroid cancer biomarkers.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  93. COYNE C, Afkhami M, Karunamurthy A, Chiosea SI, et al
    Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF K601E Mutation.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  94. ARAGON HAN P, Weng CH, Khawaja HT, Nagarajan N, et al
    MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  95. BOUCAI L, Wang LY, Smith AW, Palmer FL, et al
    Response to: Letter to the Editor Regarding the Article "Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma".
    Thyroid. 2015.
    PubMed     Text format    


  96. ROSARIO PW, Furtado MS, Mourao GF, Calsolari MR, et al
    Patients with Papillary Thyroid Carcinoma at Intermediate Risk of Recurrence According to American Thyroid Association Criteria Can Be Reclassified as Low Risk When the Postoperative Thyroglobulin Is Low.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  97. DANILOVIC DL, de Camargo RY, Castro G Jr, Papadia C, et al
    Rapid Control of T3 Thyrotoxicosis in Patients with Metastatic Follicular Thyroid Cancer Treated with Lenvatinib.
    Thyroid. 2015.
    PubMed     Text format    


  98. ATKINS F, Van Nostrand D, Moreau S, Burman K, et al
    Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of I.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  99. FERRIS RL, Carty SE
    Response to Letter to the Editor on COI for American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format    


  100. NIKIFOROV YE, Carty SE, Chiosea SI, Coyne C, et al
    Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  101. SHRESTHA RT, Karunamurthy A, Amin K, Nikiforov YE, et al
    Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management - A Case Report.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  102. KLOOS RT, Kennedy GC
    Response to "American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making".
    Thyroid. 2015.
    PubMed     Text format    


  103. KIM D, Hwang SH, Cha J, Jo K, et al
    Risk Stratification of Thyroid Incidentalomas Found on PET/CT: The Value of Iodine Content on Noncontrast Computed Tomography.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    August 2015
  104. TOLEDO RA, Maciel RM, Erlic Z, Lourenco DM Jr, et al
    RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid Carcinoma.
    Thyroid. 2015;25:973-4.
    PubMed     Text format    


    July 2015
  105. MCLEOD DS, Jonklaas J, Brierley J, Ain KB, et al
    Reassessing the NTCTCS staging systems for differentiated thyroid cancer, including age at diagnosis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  106. DADU R, Hu MI, Cleeland CS, Busaidy N, et al
    The efficacy of the natural clay, Calcium Aluminosilicate Anti-Diarrheal (CASAD), in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life: a pilot study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  107. SCHNEIDER P, Schneider R, Schneider M, Reiners C, et al
    Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  108. SINGH OSPINA NM, Sebo TJ, Morris JC 3rd, Castro MR, et al
    The value of repeat thyroid fine needle aspiration biopsy in patients with a previously benign result: How often does it alter management?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  109. AL AFIF A, Williams BA, Rigby MH, Bullock M, et al
    Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  110. SUNG TY, Kim M, Kim TY, Kim WG, et al
    Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  111. GANLY I, Nixon IJ, Wang LY, Palmer FL, et al
    Survival from differentiated thyroid cancer What has age got to do with it?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  112. ROSARIO PW, Calsolari MR
    What is the best criterion for repetition of fine-needle aspiration in thyroid nodules with initially benign cytology?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  113. DE BIASE D, Gandolfi G, Ragazzi M, Eszlinger M, et al
    TERT PROMOTER MUTATIONS IN THYROID PAPILLARY MICROCARCINOMAS.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  114. SEO GH, Cho YY, Chung JH, Kim SW, et al
    Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  115. WIEBEL JL, Esfandiari NH, Papaleontiou M, Worden FP, et al
    Evaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  116. VACCARELLA S, Dal Maso L, Laversanne M, Bray F, et al
    The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  117. LARRIVEE-VANIER S, Magne F, Patey N, Chanoine JP, et al
    Conserved telomere length in human ectopic thyroids: an argument against premature differentiation causing arrested migration.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  118. PITOIA F, Jerkovich F, Urciuoli C, Schmidt A, et al
    Implementing the Modified 2009 American Thyroid Association Risk Stratification System in thyroid cancer patients with low and intermediate risk of recurrence.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  119. RALHAN R, Veyhl J, Chaker S, Assi J, et al
    Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine Needle Aspiration Biopsy Clinical Application.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    June 2015
  120. WANG LY, Ghossein R Md, Palmer FL, Nixon IJ, et al
    Microscopic Positive Margins in differentiated thyroid cancer is not an independent predictor of local failure.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  121. STRICKLAND KC, Howitt BE, Marqusee E, Alexander EK, et al
    The Impact of Non-Invasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine Needle Aspiration Diagnostic Categories.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  122. BRITO JP, AlNofal A, Montori V, Hay ID, et al
    The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  123. LAFRANCHI SH
    Inaugural Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer: Children Are Not Small Adults.
    Thyroid. 2015.
    PubMed     Text format    


  124. SCHEFFEL RS, Zanella AB, Antunes D, Dora JM, et al
    Low Recurrence Rates in a Cohort of Differentiated Thyroid Carcinoma Patients: a Referral Center Experience.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    May 2015
  125. HINSON AM, Kandil E, O'Brien S, Spencer HJ, et al
    Trends in Robotic Thyroid Surgery in the United States from 2009 through 2013.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  126. KIM W, Chung SH, Ban E, Lee CR, et al
    Is preoperative vitamin D deficiency a risk factor for postoperative symptomatic hypocalcemia in thyroid cancer patients undergoing total thyroidectomy plus central compartment neck dissection?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  127. DEANDREA M, Sung JY, Limone PP, Mormile A, et al
    Efficacy and Safety of Radiofrequency Ablation versus Control Condition for Nonfunctioning Benign Thyroid Nodules: A Randomized Controlled International Collaborative Trial.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  128. FERRIS RL, Baloch ZW, Bernet V, Chen A, et al
    American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: current impact on perioperative decision-making.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  129. SCHOELWER M, Zimmerman D, Shore RM, Josefson JL, et al
    The Use of 123I in Diagnostic Radioactive Iodine Uptake Scans in Children with Differentiated Thyroid Carcinoma.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  130. CHOI SH, Baek JH, Lee JH, Choi YJ, et al
    Evaluation of the clinical usefulness of BRAFV600E mutation analysis of core-needle biopsy specimens in thyroid nodules with previous atypia of undetermined significance (AUS) or follicular lesions of undetermined significance (FLUS) results.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  131. MARTI JL, Davies L, Haymart MR, Roman BR, et al
    Inappropriate use of radioactive iodine for low-risk papillary thyroid cancer is most common in regions with poor access to health care.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  132. BRAUNER E, Holmes BJ, Krane J, Nishino M, et al
    Performance of the Afirma Gene Expression Classifier in Hurthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  133. MOND M, Bullock M, Yao Y, Clifton-Bligh RJ, et al
    Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  134. HANLEY JP, Jackson E, Morrissey LA, Rizzo DM, et al
    Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    April 2015
  135. KIM SM, Kim HK, Chang H, Kim KJ, et al
    Recovery from Permanent Hypoparathyroidism after Total Thyroidectomy.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  136. FRANCIS G, Waguespack SG, Bauer AJ, Angelos P, et al
    Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  137. NAKAMURA H, Hirokawa M, Ota H, Kihara M, et al
    Is an increase in thyroid nodule volume a risk factor for malignancy?
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  138. MARTI JL, Jain KS, Morris LG
    Increased risks of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  139. YI KS, Kim JH, Na DG, Seo H, et al
    Usefulness of Core Needle Biopsy for Thyroid Nodules with Macrocalcifications: Comparison with Fine Needle Aspiration.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  140. WEISS RJ, Magner J
    Serial Measurements of Serum Thyroglobulin in Response to Recombinant Human Thyrotropin (rhTSH) Stimulation.
    Thyroid. 2015.
    PubMed     Text format    


  141. WU JX, Beni CE, Zanocco K, Sturgeon C, et al
    Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low Risk Papillary Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    March 2015
  142. MORLEY S, Goldfarb M
    Support Needs and Survivorship Concerns of Thyroid Cancer Patients.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  143. RANDOLPH G, Sritharan N, Song P, Franco R, et al
    Thyroidectomy in the Professional Singer-Neural Monitored Surgical Outcomes.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  144. KEEGAN T, Grogan R, Parsons H, Tao L, et al
    Socio-demographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  145. KLOPPER J, Kane MA, Jimeno A, Sams S, et al
    A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  146. HOANG JK, Langer JE, Middleton WD, Wu CC, et al
    Misinterpretation of the American College of Radiology White Paper on Managing Incidental Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format    


  147. ROSARIO PW, Mourao GF, Siman TL, Calsolari MR, et al
    Serum thyroglobulin measured with a second-generation assay in patients undergoing total thyroidectomy without radioiodine remnant ablation: A prospective study.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  148. REMONTI LR, Kramer CK, Leitao CB, Pinto LC, et al
    Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  149. SEMRAD T, Semrad A, Farwell DG, Chen Y, et al
    Initial Treatment Patterns in Younger Adult Patients with Differentiated Thyroid Cancer in California.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  150. MEDAPATI MR, Dahlmann M, Ghavami S, Pathak KA, et al
    RAGE mediates the pro-migratory response of extracellular S100A4 in human thyroid cancer cells.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    February 2015
  151. HAYASE S, Sasaki Y, Matsubara T, Seo D, et al
    Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  152. PERTICONE F, Pigliaru F, Mariotti S, Deiana L, et al
    IS THE INCIDENCE OF DIFFERENTIATED THYROID CANCER INCREASED IN PATIENTS WITH TSH-SECRETING ADENOMA? REPORT OF THREE CASES FROM A LARGE CONSECUTIVE SERIES OF TSH-OMA.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    January 2015
  153. NASCIMENTO C, Borget I, Al Ghuzlan A, Deandreis D, et al
    Post-operative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT): an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  154. CHAMI L, Hartl DM, Leboulleux S, Baudin E, et al
    PREOPERATIVE LOCALIZATION OF NECK RECURRENCES FROM THYROID CANCER: CHARCOAL TATTOOING UNDER ULTRASOUND GUIDANCE.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  155. CHOUGNET CN, Borget I, Leboulleux S, de la Fouchardiere C, et al
    Vandetanib for the treatment of advanced medullary thyroid cancer outside a trial: results from a French cohort.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  156. BURYK MA, Simons JP, Picarsic JL, Monaco SE, et al
    Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  157. TUFANO R, Noureldine SI, Angelos P
    Ethical Responsibilities of Caring for Patients with Incidental Thyroid Nodules.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  158. FENG X, Milas M, O'Malley M, LaGuardia L, et al
    Characteristics of Benign and Malignant Thyroid Disease in Familial Adenomatous Polyposis Patients and Recommendations for Disease Surveillance.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  159. LYLE M, Dean D
    Ultrasound Guided Fine Needle Aspiration Biopsy of Thyroid Nodules in Patients taking Novel Oral Anticoagulants.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  160. SACKS W, Wong R, Bresee C, Braunstein G, et al
    Use of Evidence-Based Guidelines Reduces I131 Treatment in Patients with Low Risk Differentiated Thyroid Cancer.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


  161. ROGOUNOVITCH T, Bychkov A, Takahashi M, Mitsutake N, et al
    The common genetic variant rs944289 at chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in Japanese population.
    Thyroid. 2015.
    PubMed     Text format     Abstract available


    December 2014
  162. MEHRA S, Tuttle RM Md, Milas M, Orloff L, et al
    Database and registry research in thyroid cancer: Striving for a new and improved national thyroid cancer database.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  163. BEUTNER U, Leowardi C, Bork U, Luthi C, et al
    Survival after renal cell carcinoma metastasis to the thyroid. Single center experience and systematic review of the literature.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    November 2014
  164. ALPERT EH, Wenig B, Dewey E, Su HK, et al
    Size Distribution of Metastatic Lymph Nodes with Extranodal Extension in Patients with Papillary Thyroid Cancer: A Pilot Study.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  165. NAGARAJAN N, Schneider EB, Ali SZ, Zeiger MA Md, et al
    How Do Liquid Based Preparations of Thyroid FNA Compare with Conventional Smears? An Analysis of 5475 Specimens.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  166. BARNES JA, Davies L
    Reading grade level and completeness of freely available materials on thyroid nodules: There is work to be done.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  167. TO J, Goldberg AS, Jones J, Zhang J, et al
    A Systematic Review of Randomized Controlled Trials for Management of Persistent Post-treatment Fatigue in Thyroid Cancer Survivors.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  168. PAPARODIS R, Jaume JC
    Response to: "Reanalysis of the Data Reveal Even Stronger Associations Between Hashimoto's Thyroiditis and Differentiated Thyroid Cancer"
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  169. OROSCO RK, Hussain T, Brumund KT, Oh DK, et al
    Analysis of Age and Disease Status as Predictors of Thyroid Cancer-Specific Mortality Using the Surveillance, Epidemiology, and End Results Database.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    October 2014
  170. KAMBALAPALLI M, Gupta A, Prasad UR, Francis G, et al
    Ultrasound Characteristics of The Thyroid in Children and Adolescents with Goiter - A Single Center Experience.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  171. LINDSEY SC, Ganly I, Palmer FL, Tuttle RM Md, et al
    Response to initial therapy predicts clinical outcomes in medullary thyroid cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  172. ROSSI M, Buratto M, Tagliati F, Rossi R, et al
    Relevance of BRAFV600E mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  173. QIU ZL, Shen CT, Luo QY
    Clinical Management and Outcomes in Patients with Hyperfunctioning Distant Metastases from Differentiated Thyroid Cancer after Total Thyroidectomy and Radioactive Iodine Therapy.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  174. SUNG JY, Baek JH, Jung SL, Kim JH, et al
    Radiofrequency Ablation for Autonomously Functioning Thyroid Nodules: A Multicenter Study.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  175. WU JX, Young S, Ro K, Li N, et al
    Reproductive outcomes and non-oncologic complications after radioactive iodine ablation for well-differentiated thyroid cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  176. LI Z, Franklin JH, Zelcer S, Sexton T, et al
    Ultrasound Surveillance for Thyroid Malignancies in Survivors of Childhood Cancer Following Radiotherapy - A Single Institutional Experience.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  177. FALCHOOK GS, Millward M, Hong DS, Naing A, et al
    BRAF inhibitor dabrafenib in patients with metastatic <i>BRAF</i>-mutant thyroid cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    September 2014
  178. WANG L, Palmer FL, Nixon IJ, Thomas D, et al
    Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  179. TUFANO RP, Clayman G, Heller KS, Inabnet WB, et al
    Management of Recurrent/Persistent Nodal Disease in Patients with Differentiated Thyroid Cancer: a Critical Review of the Risks and Benefits of Surgical Intervention versus Active Surveillance.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  180. PAK K, Suh S, Kim SJ, Kim IJ, et al
    Prognostic Value of Genetic Mutations in Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  181. GUAN H, Liang W, Liu J, Wei G, et al
    TMPRSS4 promotes thyroid cancer proliferation via CREB phosphorylation.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  182. NGUYEN CT, Wang MB
    Practice Patterns in the Surgical Treatment of Papillary Thyroid Microcarcinoma.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  183. BANERJEE M, Muenz DG, Worden F, Wong SL, et al
    Conditional Survival in Thyroid Cancer Patients.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  184. BAHL M, Sosa JA, Eastwood JD, Hobbs HA, et al
    Using the 3-Tiered System for Categorizing Workup of Incidental Thyroid Nodules Detected on CT, MRI, or PET/CT: How Many Cancers Would be Missed?
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  185. YEH MW, Bauer AJ, Bernet V, Ferris RL, et al
    American Thyroid Association Statement on Preoperative Imaging for Thyroid Cancer Surgery.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  186. LICITRA L, Locati L
    Antiangiogenetic TKIs and advanced RAI-resistant thyroid cancer: time for treatment strategy rethinking ?
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    August 2014
  187. WANG LY, Palmer FL, Nixon IJ, Thomas D, et al
    Multiorgan distant metastases confer worse disease specific survival in differentiated thyroid cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  188. KIM JR, Kim BH, Kim SM, Oh MY, et al
    Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  189. CABANILLAS M, Brose M, Holland J, Ferguson KC, et al
    A phase I study of cabozantinib (XL184) in patients with differentiated thyroid cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  190. CAMPENNI A, Giovanella L, Siracusa M, Stipo ME, et al
    Is the malignant nodule topography an additional risk factor for metastatic disease in low risk differentiated thyroid cancer?
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  191. JONKLAAS J
    Nasal Symptoms After Radioiodine Therapy: a Rarely Described Side Effect With Similar Frequency to Lacrimal Dysfunction.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    July 2014
  192. RIJNTJES E, Schomburg L
    Oh, no-equations! Reanalysis of the data reveal even stronger associations between Hashimoto's thyroiditis and differentiated thyroid cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  193. ROMAN BR, Feingold JH, Patel SG, Shaha AR Md, et al
    The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  194. TRONKO MD, Saenko V, Shpak VM, Bogdanova TI, et al
    Age distribution of childhood thyroid cancer patients in Ukraine after Chernobyl and in Fukushima after the TEPCO-Fukushima Daiichi NPP accident.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  195. JEON TJ, Lee YS, Lee JH, Chang HS, et al
    Rebound Thymic Hyperplasia Detected by 18F-FDG PET/CT after Radioactive Iodine Ablation Therapy for Thyroid Cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  196. SMALLRIDGE RC, Diehl N, Bernet V
    Practice Trends in Patients with Persistent Detectable Thyroglobulin and Negative Diagnostic Radioiodine Whole Body Scans: A Survey of American Thyroid Association Members.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  197. DOS REIS LL, Tuttle RM Md, Alon E, Bergman DA, et al
    What is the "Gold Standard" for comprehensive inter-institutional communication of perioperative information for thyroid cancer patients? A comparison of existing electronic health records with the current ATA recommendations.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    June 2014
  198. SU HK, Dos Reis LL, Lupo M, Milas M, et al
    Striving Towards Standardization of Reporting of Ultrasound Features of Thyroid Nodules and Lymph Nodes: A Multidisciplinary Consensus Statement.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  199. FATOURECHI V, Morris JC 3rd, Sebo TJ
    Coexistence of Radioactive Iodine Resistant Benign Struma Ovarii With Cervical Primary Papillary Cancer of Thyroid: An Unusual Cause of Thyroglobulin-Positive Radioactive Iodine-Negative Whole-Body Scans.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  200. LACOUTURE ME, Ciccolini K, Kloos RT, Agulnik M, et al
    Overview and Management of Dermatologic Events Associated With Targeted Therapies for Medullary Thyroid Cancer.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    May 2014
  201. BEAUDENON-HUIBREGTSE S, Alexander EK, Guttler RB, Hershman J, et al
    Centralized molecular testing for oncogenic gene mutations complements the local cytopathological diagnosis of thyroid nodules.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  202. ARMSTRONG MJ, Huaitao Y, Yip L, Ohori PN, et al
    PAX8/PPARgamma Rearrangement in Thyroid Nodules Predicts Follicular-Pattern Carcinomas, in Particular the Encapsulated Follicular Variant of Papillary Carcinoma.
    Thyroid. 2014.
    PubMed     Text format     Abstract available


  203. SILVA MC, Furlanetto TW
    Another possible contributor to hyponatremia after radioactive iodine.
    Thyroid. 2014;24:923.
    PubMed     Text format    


    February 2014
  204. MEHRA S, Tuttle RM Md, Bergman DA, Bernet V, et al
    Improving the Quality of Thyroid Cancer Care: How Does the Thyroid Cancer Care Collaborative Cross the Institute of Medicine's Quality Chasm?
    Thyroid. 2014.
    PubMed     Text format     Abstract available


    December 2013
  205. ZEVALLOS JP, Xu L, Yiu Y
    The Impact of Socioeconomic Status on the Use of Adjuvant Radioactive Iodine for Papillary Thyroid Cancer.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


  206. BENBASSAT C
    Evidence is not sufficient to recommend a more aggressive approach to Familial Nonmedullary Thyroid Cancer.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


    November 2013
  207. ZHANG L, Gaskin K, Yu Z, Xiong Y, et al
    An in vivo Mouse Model of Human Thyroid Cancer Metastasis.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


    October 2013
  208. YIM JH , Kim WG, Jeon M, Han JM, et al
    Association between Expression of X-linked Inhibitor of Apoptosis Protein and the Clinical Outcome in BRAFV600E Prevalent Papillary Thyroid Cancer Population.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


  209. VERSARI A , Sollini M, Frasoldati A, Fraternali A, et al
    Differentiated thyroid cancer: a new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


  210. KIM SK , Yun GY, Kim KH, Park SK, et al
    Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


  211. THOMPSON AM , Turner RM, Hayen A, Aniss A, et al
    A Pre-operative Nomogram for the Prediction of Ipsilateral Central Compartment Lymph Node Metastases in Papillary Thyroid Cancer.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


    April 2013
  212. SCARPINO S , Duranti E, Giglio S, Di Napoli A, et al
    PAPILLARY CARCINOMA OF THE THYROID: HIGH EXPRESSION OF COX-2 AND LOW EXPRESSION OF KAI-1/CD82 ARE ASSOCIATED WITH INCREASED TUMOUR INVASIVENESS.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


    February 2013
  213. LONDERO SC , Krogdahl A, Bastholt L, Overgaard J, et al
    Papillary thyroid microcarcinoma in Denmark 1996-2008: A national study of epidemiology and clinical significance.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


  214. TONG A , Xia W, Qi F, Jin Z, et al
    Hyperthyroidism caused by an ectopic thyrotropin-secreting tumor of the nasopharynx: a case report and review of the literature.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


  215. LEBOULLEUX S , Borget I, Labro S, Bidault S, et al
    Frequency and intensity of pain related to thyroid nodule fine needle aspiration cytology.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


    January 2013
  216. JONKLAAS J , Danielsen M, Wang H
    A Pilot Study of Serum Selenium, Vitamin D, and TSH Concentrations in Patients with Thyroid Cancer.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


  217. LEE J , Lee SY, Cha SH, Cho BS, et al
    Fine Needle Aspiration of Thyroid Nodules with Macrocalcification.
    Thyroid. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: